• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM FRAMING COIL; DEVICE, EMBOLIZATION, VASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM FRAMING COIL; DEVICE, EMBOLIZATION, VASCULAR Back to Search Results
Model Number FC-3.5-8-3D
Medical Device Problem Codes Difficult or Delayed Positioning (1157); Detachment of Device or Device Component (2907); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code Thrombus (2101)
Date of Event 07/09/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Medtronic received information regarding an axium framing coil that detached prematurely.The patient was being treated for a ruptured aneurysm.The aneurysm max diameter was 4mm and the neck diameter was 3.5mm.Vessel tortuosity was severe.It was reported that the axium coil was being used simultaneously with a competitor's coil.The axium framing coil was used for the first frame, and the competitor's coil for the second frame.The surgeon inserted the coil and pulled out several times.The axium coil was prematurely detached.The surgeon had not made any attempts to detach the coil when the issue occurred.The surgeon removed the axium coil and competitor's coil with a micro snare.Continuous catheter flush was provided during the procedure.The coil was discarded and replaced with a competitor's product.The patient developed a thrombus during the procedure while the prematurely detached coil was being pulled out.
 
Additional Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
Additional information received reported that there was difficulty positioning the coils and poor framing.There was no resistance or friction when the physician pulled the coil out, and no kink/damage was observed on the pushwire.It was unknown if the patient was currently symptomatic.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM FRAMING COIL
Common Device Name
DEVICE, EMBOLIZATION, VASCULAR
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
MDR Report Key10316899
Report Number2029214-2020-00718
Device Sequence Number2890141
Product Code KRD
UDI-Device Identifier00847536034099
UDI-Public00847536034099
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K162704
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Device Explanted Year2020
Reporter Type Manufacturer
Report Source company representative,distri
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/07/2022
Device Model NumberFC-3.5-8-3D
Device Catalogue NumberFC-3.5-8-3D
Device Lot NumberA910954
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/20/2020
Supplement Date Received by Manufacturer08/01/2020
Initial Report FDA Received Date07/23/2020
Supplement Report FDA Received Date08/06/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-